Publications by authors named "Austin Rayford"

Claim this Profile
H
HIDE: hierarchical cell-type deconvolution.
Dennis Völkl, Malte Mensching-Buhr, Thomas Sterr, Sarah Bolz, Andreas Schäfer, Austin Rayford

Bioinformatics· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting AXL cellular networks in kidney fibrosis.
Sturla M Grøndal, Magnus Blø, Linn I H Nilsson, Austin J Rayford, Akil Jackson

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy.
Austin Rayford, Fabian Gärtner, Maria P Ramnefjell, James B Lorens, David R Micklem

Front Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid Models.
Maria L Lotsberg, Gro V Røsland, Austin J Rayford, Sissel E Dyrstad, Camilla T Ekanger

Front Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AXL targeting restores PD-1 blockade sensitivity of mutant NSCLC through expansion of TCF1 CD8 T cells.
Huiyu Li, Zhida Liu, Longchao Liu, Hongyi Zhang, Chuanhui Han, Austin Rayford

Cell Rep Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding cancer's camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade.
Maria L Lotsberg, Austin Rayford, Jean Paul Thiery, Giuliana Belleggia, Stacey D'Mello Peters

Cancer Drug Resist· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells.
Maria L Lotsberg, Katarzyna Wnuk-Lipinska, Stéphane Terry, Tuan Zea Tan, Ning Lu, Austin Rayford

J Thorac Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis